Paper41511291
Human Cardiac Organoids: Advances and Prospects from Construction to Preclinical Drug Evaluation.
Chen M and 9 others. Cells, 2025. Cited by 10 papers, by iCite.
Cite this record
ConductScience Library. Human Cardiac Organoids: Advances and Prospects from Construction to Preclinical Drug Evaluation. Papers, record 41511291. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41511291
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Human Cardiac Organoids: Advances and Prospects from Construction to Preclinical Drug Evaluation.
- PubMed
Topics6
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Organoids | Major topic |
| Heart | Major topic |
| Humans | |
| Drug Evaluation, Preclinical | |
| Pluripotent Stem Cells | |
| Animals |
Source PubMed
Grants3
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| Nos.82473673 | National Natural Science Foundation of China | PubMed | ||
| BE2023720 | the Key Research and Development Plan (Social Development) Project of Jiangsu Province | PubMed | ||
| BK20222008 | Natural Science Foundation of Jiangsu Province, Major Project | PubMed |
Source PubMed
References124
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 30415499 | Human Cardiac Organoids for Disease Modeling. | Clin Pharmacol Ther | 2019 | https://conductscience.org/library/papers/30415499 | PubMed |
| 2 | 30930147 | Drug Screening in Human PSC-Cardiac Organoids Identifies Pro-proliferative Compounds Acting via the Mevalonate Pathway. | Cell Stem Cell | 2019 | https://conductscience.org/library/papers/30930147 | PubMed |
| 3 | 33629131 | Human-induced pluripotent stem cell-derived cardiomyocytes, 3D cardiac structures, and heart-on-a-chip as tools for drug research. | Pflugers Arch | 2021 | https://conductscience.org/library/papers/33629131 | PubMed |
| 4 | 36982261 | Advances in 3D Organoid Models for Stem Cell-Based Cardiac Regeneration. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/36982261 | PubMed |
| 5 | 40472086 | Gastruloids enable modeling of the earliest stages of human cardiac and hepatic vascularization. | Science | 2025 | https://conductscience.org/library/papers/40472086 | PubMed |
| 6 | 31911598 | Generating ring-shaped engineered heart tissues from ventricular and atrial human pluripotent stem cell-derived cardiomyocytes. | Nat Commun | 2020 | https://conductscience.org/library/papers/31911598 | PubMed |
| 7 | 28174241 | Development of a human cardiac organoid injury model reveals innate regenerative potential. | Development | 2017 | https://conductscience.org/library/papers/28174241 | PubMed |
| 8 | 29976997 | Characterization and Validation of a Human 3D Cardiac Microtissue for the Assessment of Changes in Cardiac Pathology. | Sci Rep | 2018 | https://conductscience.org/library/papers/29976997 | PubMed |
| 9 | 37889357 | Recent advances in pluripotent stem cell-derived cardiac organoids and heart-on-chip applications for studying anti-cancer drug-induced cardiotoxicity. | Cell Biol Toxicol | 2023 | https://conductscience.org/library/papers/37889357 | PubMed |
| 10 | 37081739 | Standardization of organoid culture in cancer research. | Cancer Med | 2023 | https://conductscience.org/library/papers/37081739 | PubMed |
| 11 | 34446706 | Self-assembling human heart organoids for the modeling of cardiac development and congenital heart disease. | Nat Commun | 2021 | https://conductscience.org/library/papers/34446706 | PubMed |
| 12 | 40562874 | Maturation of human cardiac organoids enables complex disease modeling and drug discovery. | Nat Cardiovasc Res | 2025 | https://conductscience.org/library/papers/40562874 | PubMed |
| 13 | 37012447 | Epicardioid single-cell genomics uncovers principles of human epicardium biology in heart development and disease. | Nat Biotechnol | 2023 | https://conductscience.org/library/papers/37012447 | PubMed |
| 14 | 19329995 | Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche. | Nature | 2009 | https://conductscience.org/library/papers/19329995 | PubMed |
| 15 | 37215622 | Organoids: The current status and biomedical applications. | MedComm (2020) | 2023 | https://conductscience.org/library/papers/37215622 | PubMed |
| 16 | 18514247 | Characterizing interspecies uncertainty using data from studies of anti-neoplastic agents in animals and humans. | Toxicol Appl Pharmacol | 2008 | https://conductscience.org/library/papers/18514247 | PubMed |
| 17 | 39522593 | Engineering organoids-on-chips for drug testing and evaluation. | Metabolism | 2025 | https://conductscience.org/library/papers/39522593 | PubMed |
| 18 | 39911371 | Engineering cardiology with miniature hearts. | Mater Today Bio | 2025 | https://conductscience.org/library/papers/39911371 | PubMed |
| 19 | 34292882 | Gain-of-function mutation in ubiquitin-ligase KLHL24 causes desmin degradation and dilatation in hiPSC-derived engineered heart tissues. | J Clin Invest | 2021 | https://conductscience.org/library/papers/34292882 | PubMed |
| 20 | 36444237 | Cellular and Molecular Mechanisms of MEK1 Inhibitor-Induced Cardiotoxicity. | JACC CardioOncol | 2022 | https://conductscience.org/library/papers/36444237 | PubMed |
Cited by5
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 10 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42738882 | Molecular Pathways, Target Landscape, and Translational Models in Heart Failure with Preserved Ejection Fraction. | Cells | 2026 | https://conductscience.org/library/papers/42738882 | PubMed |
| 42421236 | Human iPSC-derived 3D cardiac models for cardiomyopathies: organoids, spheroids, and engineered heart tissues as translational platforms. | Stem Cells | 2026 | https://conductscience.org/library/papers/42421236 | PubMed |
| 42414695 | Injectable bioactive hydrogels as pharmacological drug delivery platforms for post-myocardial infarction cardiac repair: therapeutic cargo engineering, stimuli-responsive release mechanisms, and translational perspectives. | Naunyn Schmiedebergs Arch Pharmacol | 2026 | https://conductscience.org/library/papers/42414695 | PubMed |
| 42365336 | Cardiac organoids in toxicology: from construction strategies and research trends to precision screening applications. | Stem Cell Res Ther | 2026 | https://conductscience.org/library/papers/42365336 | PubMed |
| 42278198 | Developmental Programming of Drug Response: Microbiota as a Missing Dimension in Perinatal Drug Discovery. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42278198 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41511291
GET https://conductscience.org/api/papers/v1/41511291/references?page=2